🇺🇸 FDA
Pipeline program

Sonrotoclax

BGB-11417-101

Phase 1 small_molecule active

Quick answer

Sonrotoclax for Mature B-Cell Malignancies is a Phase 1 program (small_molecule) at BEONE MEDICINES AUS PTY LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
BEONE MEDICINES AUS PTY LTD
Indication
Mature B-Cell Malignancies
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials